X-102715310-G-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001004051.4(GPRASP2):c.441G>T(p.Gln147His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000759 in 1,211,615 control chromosomes in the GnomAD database, including 1 homozygotes. There are 40 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001004051.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPRASP2 | NM_001004051.4 | c.441G>T | p.Gln147His | missense_variant | 5/5 | ENST00000483720.7 | |
ARMCX5-GPRASP2 | NR_146584.3 | n.795+1044G>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPRASP2 | ENST00000483720.7 | c.441G>T | p.Gln147His | missense_variant | 5/5 | 2 | NM_001004051.4 | P1 | |
ARMCX5-GPRASP2 | ENST00000652409.1 | c.-756+1044G>T | intron_variant | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000265 AC: 3AN: 113387Hom.: 0 Cov.: 25 AF XY: 0.0000282 AC XY: 1AN XY: 35513
GnomAD3 exomes AF: 0.000147 AC: 27AN: 183166Hom.: 0 AF XY: 0.000222 AC XY: 15AN XY: 67620
GnomAD4 exome AF: 0.0000810 AC: 89AN: 1098177Hom.: 1 Cov.: 31 AF XY: 0.000107 AC XY: 39AN XY: 363533
GnomAD4 genome AF: 0.0000264 AC: 3AN: 113438Hom.: 0 Cov.: 25 AF XY: 0.0000281 AC XY: 1AN XY: 35574
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 10, 2023 | The c.441G>T (p.Q147H) alteration is located in exon 5 (coding exon 1) of the GPRASP2 gene. This alteration results from a G to T substitution at nucleotide position 441, causing the glutamine (Q) at amino acid position 147 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at